Vidofludimus
Vidofludimus (SC12267, 4SC-101) is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 134 nM for human DHODH. Vidofludimus calcium (IMU-838) is investigated as a potential treatment option for COVID-19. Phase 2.
Supplier | Selleck Chemicals |
---|---|
Product # | S7262 |
Sku # | S7262-5mg |
Pricing | 5mg, $147.00 |